{"organizations": [], "uuid": "3fab3aaf077d9cea0f7f865ff663b56cd9f16a8a", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180125.html", "section_title": "Archive News &amp; Video for Thursday, 25 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-pixium-vision-announces-human-impl/brief-pixium-vision-announces-human-implantation-and-activation-of-prima-bionic-vision-system-idUSFWN1PK1K3", "country": "US", "domain_rank": 408, "title": "BRIEF-Pixium Vision Announces Human Implantation And Activation Of PRIMA Bionic Vision System", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-26T01:20:00.000+02:00", "replies_count": 0, "uuid": "3fab3aaf077d9cea0f7f865ff663b56cd9f16a8a"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-pixium-vision-announces-human-impl/brief-pixium-vision-announces-human-implantation-and-activation-of-prima-bionic-vision-system-idUSFWN1PK1K3", "ord_in_thread": 0, "title": "BRIEF-Pixium Vision Announces Human Implantation And Activation Of PRIMA Bionic Vision System", "locations": [], "entities": {"persons": [], "locations": [{"name": "prima", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "amd", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "gdynia newsroom", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 25 (Reuters) - PIXIUM VISION SA:\n* ANNOUNCES TODAY WORLDâ€˜S FIRST SUCCESSFUL HUMAN IMPLANTATION AND ACTIVATION OF PRIMA,\n* PRIMA IS A NEW GENERATION MINIATURIZED WIRELESS PHOTOVOLTAIC SUB-RETINAL IMPLANT\n* PRIMA WAS IMPLANTED IN PATIENT WITH SEVERE VISION LOSS FROM ATROPHIC DRY AGE-RELATED MACULAR DEGENERATION (AMD)\n* PATIENT TO START RE-EDUCATION PHASE AS PER TRIAL PROTOCOL\n* STUDY TO RECRUIT UP TO 5 PATIENTS WITH EVALUATION AT 6M FOLLOW-UP, AND LONGER-TERM FOLLOW-UP TO 36 MTHS Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-01-26T01:20:00.000+02:00", "crawled": "2018-01-26T21:19:58.002+02:00", "highlightTitle": ""}